Vanguard Group Inc Codexis, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,258,201 shares of CDXS stock, worth $14.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,258,201

Previous 4,128,428 3.14%

Holding current value

$14.4 Million

Previous $12.6 Million 18.03%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.59 - $4.65 $336,112 - $603,444	129,773 Added 3.14%	4,258,201 $14.9 Million
Q4 2023 Feb 14, 2024	BUY	$1.54 - $3.37 $138,111 - $302,231	89,683 Added 2.22%	4,128,428 $12.6 Million
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.75 $520,369 - $1.3 Million	346,913 Added 9.4%	4,038,745 $7.63 Million
Q2 2023 Aug 14, 2023	SELL	$2.21 - $4.43 $146,874 - $294,413	-66,459 Reduced 1.77%	3,691,832 $10.3 Million
Q1 2023 May 15, 2023	BUY	$3.81 - $6.76 $442,276 - $784,721	116,083 Added 3.19%	3,758,291 $15.6 Million

Q4 2022 Feb 10, 2023	BUY	$4.26 - $6.84 $540,159 - $867,298	126,798 Added 3.61%	3,642,208 $17 Million
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $177,412 - $376,489	29,276 Added 0.84%	3,515,410 $21.3 Million
Q2 2022 Aug 12, 2022	SELL	$8.35 - $21.89 $1.22 Million - $3.2 Million	-146,228 Reduced 4.03%	3,486,134 $36.5 Million
Q1 2022 May 13, 2022	BUY	$16.97 - $31.93 $3.93 Million - $7.4 Million	231,872 Added 6.82%	3,632,362 $74.9 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $41.78 $4.76 Million - $7.77 Million	185,898 Added 5.78%	3,400,490 $106 Million
Q3 2021 Nov 12, 2021	BUY	$19.65 - $27.99 $582,740 - $830,071	29,656 Added 0.93%	3,214,592 $74.8 Million
Q2 2021 Aug 13, 2021	BUY	$17.48 - $25.46 $55.7 Million - $81.1 Million	3,184,936 New	3,184,936 $72.2 Million

Others Institutions Holding CDXS

# of Institutions

131

Shares Held

49.5M

Call Options Held

33.4K

Put Options Held

21K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $221M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Codexis, Inc. Transaction History